Gemcitabine induction chemotherapy in non-small cell lung cancer

Seminars in Oncology

Volumn 29, Issue 3 SUPPL. 9, 2002, Pages 55-60

  Depierre, Alain ^a   Westeel, Virginie ^a   Jacoulet, Pascale ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036314481     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.34277     Document Type: Conference Paper

References (40)

1. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
2. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer
3. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
4. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma
5. Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report
6. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: Results of the Toronto Phase II Trial
7. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small-cell lung cancer
8. Preoperative chemotherapy and immunochemotherapy for locally advanced stage IIIA and IIIB non-small-cell lung cancer. Preliminary results
9. Neoadjuvant treatment of stage IIIA non-small-cell lung cancer. Long-term results
10. Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small-cell lung cancer
11. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
12. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer
13. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer
14. Neoadjuvant therapy: A novel and effective treatment for stage IIIb nonsmall-cell lung cancer
15. Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small-cell lung cancer: Problems and progress from the perspective of long-term follow-up
16. Multidisciplinary approach to the treatment of locally and regionally advanced non-small-cell lung cancer: University of Miami experience
17. Results of Cancer and Leukemia Group B protocol 8935. A multi-institutional phase II trimodality trial for stage IIIA (N2) nonsmall-cell lung cancer
18. Traitements préopératoires des cancers bronchiques
19. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small-cell carcinoma. Results from a randomized phase II trial
20. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
21. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
22. Chemotherapy plus surgery versus surgery alone in non-small-cell lung cancer
23. Chemotherapy and surgery versus surgery alone in non-small-cell lung cancer
24. Comment on Rosell et al, Roth et al, and Gandara et al, Lung Cancer
25. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
26. Phase III trial of neo-adjuvant chemotherapy (NCT) in resectable stage I (except T1N0), II, IIIa non-small-cell lung cancer: The French experience
27. Updated results of the French phase III trial of preoperative chemotherapy (PCT) in resectable non-small-cell lung cancer (NSCLC)
28. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and III non-small-cell lung cancer
29. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)
30. Induction chemotherapy with gemcitabine and cisplatin in locally advanced non-small-cell lung cancer: A phase II study
31. Neoadjuvant chemotherapy with gemcitabine and platinum in unresectable stage III non-small-cell lung cancer (NSCLC): A phase II experience with a new schedule
32. Preoperative chemotherapy (CHT) with cisplatin and gemcitabine in locally advanced (LA), unresectable non-small-cell lung cancer (NSCLC)
33. Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/ IIIB non-small-cell lung cancer (NSCLC). A mono-institutional phase II study with a 21 days schedule
34. Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): A phase I trial with stage III non-small-cell lung cancer (NSCLC)
35. Phase I study of gemcitabine (G) and high-dose thoracic radiation (RT) in stage III non-small-cell lung cancer (NSCLC)
36. Phase I/Il study of gemcitabine combined with cisplatin weekly and concurrent thoracic MV-radiotherapy for patients with stage IIIA/B non-small-cell lung cancer (NSCLC)
37. The results of treatment in 100 patients with limited-stage small-cell lung cancer
38. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small cell lung cancer
39. Gemcitabinecisplatin chemotherapy followed by radiotherapy in locally advanced NSCLC: A phase II retrospective analysis
40. A phase II trial of high-dose gemcitabine (GEM) + cisplatin (CDDP) and sequential radiotherapy for unresectable non-small-cell lung cancer (NSCLC). Preliminary results